FDA clears Optellum's lung cancer diagnosis software

2021 03 11 21 54 5662 Computer Ai Artificial Illustration 400

The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software developer Optellum's clinical decision-support software for lung cancer diagnosis.

Virtual Nodule Clinic helps radiologists to identify and track patients with small lung lesions that could be early-stage cancer, Optellum said. It features a lung cancer prediction scoring tool based on AI and radiomics that draws features from CT scans to assess lung lesions.

Page 1 of 650
Next Page